Study of SARS-CoV-2 adjuvanted by OMVs as a vaccine platform and future perspectives iconStudy of SARS-CoV-2 adjuvanted by OMVs as a vaccine platform and future perspectives

Study of SARS-CoV-2 adjuvanted by OMVs as a vaccine platform and future perspectives

Novel Bile Salt Stabilized Nano-Colloidal Carriers For Oral Vaccine Delivery iconNovel Bile Salt Stabilized Nano-Colloidal Carriers For Oral Vaccine Delivery

Novel Bile Salt Stabilized Nano-Colloidal Carriers For Oral Vaccine Delivery

Stabilization of the SARS-CoV-2 Spike receptor-binding domain using deep mutational scanning and structure-based design iconStabilization of the SARS-CoV-2 Spike receptor-binding domain using deep mutational scanning and structure-based design

Stabilization of the SARS-CoV-2 Spike receptor-binding domain using deep mutational scanning and structure-based design

Moving beyond the titer paradigm: rational design of a next-gen glycoconjugate vaccine inducing highly functional antibodies iconMoving beyond the titer paradigm: rational design of a next-gen glycoconjugate vaccine inducing highly functional antibodies

Moving beyond the titer paradigm: rational design of a next-gen glycoconjugate vaccine inducing highly functional antibodies

First recombinant dual-hit glycoconjugate vaccine production platform to combat Group A Streptococcus iconFirst recombinant dual-hit glycoconjugate vaccine production platform to combat Group A Streptococcus

First recombinant dual-hit glycoconjugate vaccine production platform to combat Group A Streptococcus

Vaccine nanoparticles for elicitation of strong cellular and humoral immune responses. iconVaccine nanoparticles for elicitation of strong cellular and humoral immune responses.

Vaccine nanoparticles for elicitation of strong cellular and humoral immune responses.

Using synthetic biology to generate rapidly manufacturable hyper-stable vaccines iconUsing synthetic biology to generate rapidly manufacturable hyper-stable vaccines

Using synthetic biology to generate rapidly manufacturable hyper-stable vaccines

Design and immunogenicity of a Pan-SARS-CoV-2 synthetic DNA vaccine iconDesign and immunogenicity of a Pan-SARS-CoV-2 synthetic DNA vaccine

Design and immunogenicity of a Pan-SARS-CoV-2 synthetic DNA vaccine

Epitope identification of SARS-CoV-2 structural proteins using in silico approaches to obtain conserved rational immunogenic peptide iconEpitope identification of SARS-CoV-2 structural proteins using in silico approaches to obtain conserved rational immunogenic peptide

Epitope identification of SARS-CoV-2 structural proteins using in silico approaches to obtain conserved rational immunogenic peptide

Potent neutralizing humoral and cellular responses induced by SARS-CoV-2 Spike protein – polymeric glyco-adjuvant conjugate iconPotent neutralizing humoral and cellular responses induced by SARS-CoV-2 Spike protein – polymeric glyco-adjuvant conjugate

Potent neutralizing humoral and cellular responses induced by SARS-CoV-2 Spike protein – polymeric glyco-adjuvant conjugate